Pioneering New Therapies for the Treatment of Heart Disease
More than 82 million people live with heart disease in the United States. Many of them will benefit from interventional procedures developed or refined by the Cardiovascular Research Foundation (CRF).
Still others will have their lives transformed by technologies that are only now emerging and being studied and perfected here before becoming available to patients.
Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in treating heart disease by establishing the safe use of new technologies, drugs, and therapies in interventional cardiovascular medicine. Guided by visionary physicians who are passionate about advancing the field, CRF's mission is to improve the survival and quality of life of those suffering from heart disease around the world.
CRF’s role in interventional cardiovascular medicine is unique. By providing research, evaluation, and education under one roof, CRF has the ability to generate important research questions, test and refine ground breaking new therapies, and ensure that these treatments are available to patients at the earliest opportunity.
CRF carries out its mission by pursuing three basic goals:
The CRF Skirball Center for Innovation guides early ideas and innovations through comprehensive preclinical research programs to introduce practical clinical therapies to patients.
The CRF Clinical Trials Center plans and executes clinical investigations from first-in-man studies to large, multicenter, international trials and provides expert, independent qualitative and quantitative analyses of clinical and imaging data.
The CRF Center for Education trains practitioners in advanced techniques and innovations at more than 50 educational meetings and conferences each year, including the annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
CRF is a 501(c)3 nonprofit organization.